1. Home
  2. AAPG vs WULF Comparison

AAPG vs WULF Comparison

Compare AAPG & WULF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • WULF
  • Stock Information
  • Founded
  • AAPG 2009
  • WULF 1952
  • Country
  • AAPG China
  • WULF United States
  • Employees
  • AAPG N/A
  • WULF N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • WULF EDP Services
  • Sector
  • AAPG Health Care
  • WULF Technology
  • Exchange
  • AAPG Nasdaq
  • WULF Nasdaq
  • Market Cap
  • AAPG 3.6B
  • WULF 4.5B
  • IPO Year
  • AAPG 2025
  • WULF 1995
  • Fundamental
  • Price
  • AAPG $33.87
  • WULF $11.14
  • Analyst Decision
  • AAPG Strong Buy
  • WULF Strong Buy
  • Analyst Count
  • AAPG 3
  • WULF 12
  • Target Price
  • AAPG $49.00
  • WULF $16.71
  • AVG Volume (30 Days)
  • AAPG 8.0K
  • WULF 46.3M
  • Earning Date
  • AAPG 11-19-2025
  • WULF 11-10-2025
  • Dividend Yield
  • AAPG N/A
  • WULF N/A
  • EPS Growth
  • AAPG N/A
  • WULF N/A
  • EPS
  • AAPG N/A
  • WULF N/A
  • Revenue
  • AAPG $54,524,554.00
  • WULF $167,604,000.00
  • Revenue This Year
  • AAPG N/A
  • WULF $41.01
  • Revenue Next Year
  • AAPG $368.64
  • WULF $118.36
  • P/E Ratio
  • AAPG N/A
  • WULF N/A
  • Revenue Growth
  • AAPG N/A
  • WULF 30.58
  • 52 Week Low
  • AAPG $16.50
  • WULF $2.06
  • 52 Week High
  • AAPG $48.45
  • WULF $17.05
  • Technical
  • Relative Strength Index (RSI)
  • AAPG 47.99
  • WULF 38.23
  • Support Level
  • AAPG $30.93
  • WULF $11.88
  • Resistance Level
  • AAPG $34.31
  • WULF $15.20
  • Average True Range (ATR)
  • AAPG 0.81
  • WULF 1.38
  • MACD
  • AAPG 0.26
  • WULF -0.54
  • Stochastic Oscillator
  • AAPG 85.99
  • WULF 2.87

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About WULF TeraWulf Inc.

TeraWulf Inc is a digital asset technology company that is engaged in digital infrastructure and sustainable energy development. It is involved in supporting environmentally conscious bitcoin mining operations by developing and operating facilities within the United States. The company's bitcoin mining facilities are powered by clean, affordable, and reliable energy sources. Its primary source of revenue stems from the mining of bitcoin conducted at the company's mining facility sites. Additionally, the company occasionally generates revenue through the provision of miner hosting services to third-party entities.

Share on Social Networks: